Vicini P, Amoretti L, Ballabeni V, Tognolini M, Barocelli E
Dipartimento Farmaceutico, Università degli Studi Parma, Italy.
Bioorg Med Chem. 2000 Sep;8(9):2355-8. doi: 10.1016/s0968-0896(00)00168-1.
We describe a series of 2-amino-benzo[d]isothiazol-3-one derivatives (2-8), which were synthesized and screened in vitro for inhibition of platelet aggregation and for their spasmolytic activity, with the awareness that the development of antiplatelet agents with additional vasodilation activity could be beneficial in the treatment of various vaso-occlusive disorders. The tested compounds show a powerful antiplatelet activity and various modifications resulted in molecules possessing antiaggregating effects as well as spasmolytic actions.
